InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.99 and traded as high as $6.02. InnovAge shares last traded at $6.02, with a volume of 19,742 shares.
InnovAge Trading Up 0.8 %
The firm has a fifty day simple moving average of $5.99 and a two-hundred day simple moving average of $5.21. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market capitalization of $818.65 million, a P/E ratio of -25.08 and a beta of 0.39.
InnovAge (OTCMKTS:INNV - Get Free Report) last announced its quarterly earnings results on Tuesday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $199.40 million for the quarter, compared to the consensus estimate of $190.19 million. InnovAge had a negative net margin of 6.17% and a negative return on equity of 13.04%. On average, equities research analysts anticipate that InnovAge Holding Corp. will post -0.25 earnings per share for the current fiscal year.
About InnovAge
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
See Also
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
